Related Experiment Video
Updated: Jun 29, 2025

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.6K
Cutaneous Angiosarcoma Subtypes: A Quantitative Systematic Review of Demographics, Treatments, and Outcomes Within
Zachary Kwapnoski1, Dillon Clarey2, Jihyun Ma3
1Department of Dermatology, University of California Davis, Sacramento, CA.
Summary
Cutaneous angiosarcoma (cAS) is a rare vascular cancer. This study analyzed 1,500 cases, finding elderly men most affected, with poor survival rates. Prognostic factors like metastasis and subtype significantly impact outcomes.
Area of Science:
- Oncology
- Dermatology
- Vascular Biology
Background:
- Cutaneous angiosarcoma (cAS) is a rare and aggressive vascular malignancy.
- Limited data exists on cAS demographics, management, and survival outcomes due to its rarity.
Purpose of the Study:
- To systematically compile patient-level data on cAS.
- To analyze demographics, management strategies, and survival outcomes.
- To identify prognostic indicators for cAS.
Main Methods:
- Conducted systematic literature searches across major databases (EBSCOhost, MEDLINE, EMBASE, Cochrane Library).
- Compiled data from 1,500 patient-level cases of cAS.
- Followed PRISMA guidelines for systematic reviews.
Main Results:
- cAS most frequently affects elderly men, often on the scalp.
- Metastasis occurred in 36.3% of cases, with a 5-year survival rate of 31.6%.
- Radiation-associated cAS had better survival (48.8%) than Stewart-Treves subtype (21.6%).
- Multivariate analysis identified gender, age, subtype, treatment, and metastasis as significant prognostic factors (p < .05).
Conclusions:
- This comprehensive analysis provides valuable insights into cAS.
- The findings can serve as a clinical resource for managing cutaneous angiosarcoma.
- Understanding prognostic indicators is crucial for improving patient outcomes.
Related Concept Videos
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K

